Skip to main content

Axtria driving growth from Basel

| News

Axtria driving growth from Basel

01.02.2021

The US firm Axtria has established a new office in Basel. The company offers services for the life sciences industry in the field of cloud software and data analysis. Axtria is now planning to exploit the wealth of talent and specialists in the Basel Area to drive further growth.

Jaswinder Chadha, Co-Founder and CEO of Axtria (img: Axtria)

Founded in 2010, Axtria works with the 20 leading international life sciences firms, according to information from the company itself. Headquartered in the US state of New Jersey with a stronghold in India, the provider of cloud software and data analysis solutions aims to make decision-making processes easier for its clients by offering them the tools necessary for targeted research data analysis. To provide these services, Axtria relies on well-trained employees. This is just one of the reasons why the company has now decided on Basel as a new location. Basel Area Business & Innovation, the investment and innovation promotion agency, supported Axtria during the process of founding Axtria Swiss GmbH.

Axtria presently employs around 2,000 members of staff across the world. Of this number, 800 were only hired in 2020 alone. At the company headquarters in New Jersey, Axtria has been listed as one of the state’s 50 fastest-growing companies for seven successive years. “We are proud of our substantial growth within the market, and our investments within the company reflect our commitment to continue that progress”, comments Jaswinder Chadha, co-founder and CEO of Axtria. Chadha goes on to describe Europe and the USA as the company’s most important markets. With the opening of new offices, Axtria employees will be in a position to “make an impact in the life sciences industry”.

In this context, the company also underlines that its Basel office is part of a long-term corporate strategy that aims to operate in close proximity to its customers. Basel is, after all, home to numerous companies active in the field of life sciences. Moreover, Axtria’s growth will be advanced by well-trained employees. For this reason, Basel is a prime location for the company from which it can implement plans to drive both sales and therefore growth as well.

Share this article

Sign up to receive our newsletter in your inbox.

You may also be interested in

The power of a persuasive pitch deck

Are you an entrepreneur striving to secure investment for your biotech startup? Start with an effective pitch deck to catch...
Read More

Roche investing an additional 1.2 billion Swiss francs in Basel

Roche will be putting an additional 1.2 billion Swiss francs towards the renovation of its site in Basel. This investment...
Read More

Nouscom secures 67.5 million euros in financing

Biotech company Nouscom has raised 67.5 million euros in a series C financing round. The Basel-based firm intends to use...
Read More

Celebrating six months of innovation: i4Challenge accelerator New Ideas 2022/2023

On the 5th of July 2023, the 3rd iteration of the i4Challenge accelerator program New Ideas came to its conclusion....
Read More

How open innovation in healthtech hubs is fueling the rise of digital healthcare

How the ever-increasing uptake of digital solutions is enhancing patient engagement, increasing access to care and lowering the cost of...
Read More

How to access the U.S. market with your medical device

In one of our latest Venture Mentoring events by Basel Are Business & Innovation, we invited Nila-Pia Rähle to speak...
Read More

Do you have a question? We'd like to hear from you.